Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Instrucciones importantes de administración. Ingiera las cápsulas completas; no las corte ni mastique. Linzess, linaclotida, cápsulas indicadas en el tratamiento de síndrome de intestino irritable y estreñimiento crónico idiopático en adultos. Allergan.

  2. 12 de jun. de 2023 · The recommended dosage of LINZESS is 290 mcg orally once daily. Chronic Idiopathic Constipation (CIC) in adults. The recommended dosage of LINZESS is 145 mcg orally once daily. A dosage of 72 mcg once daily may be used based on individual presentation or tolerability. Functional Constipation (FC) in pediatric patients 6 to 17 years of age.

  3. Dosage Forms & Strengths. capsule. 72mcg. Functional Constipation. Indicated for treatment of functional constipation (FC) in pediatric patients aged 6-17 years. 72 mg PO qDay. Dosage Modifications. Renal or hepatic impairment. Not expected to affect clearance of linaclotide or its active metabolite because linaclotide metabolism occurs within ...

  4. YOU COULD PAY AS LITTLE AS $30* FOR 90 OR 30 DAYS OF LINZESS. Whether you start with a 90-day or 30-day prescription, you could be eligible to pay as little as $30* with the LINZESS Savings Program. Talk to a doctor about a 90-day prescription to potentially maximize your savings and minimize trips to the pharmacy. SEE HOW YOU COULD SAVE.

  5. 26 de abr. de 2024 · Learn more about LINZESS ® and see what savings options may be available to you that can help bring down the cost of your medication. Options may include Rx Advantage Card, Copay Assistance & Coupons, Canadian Pharmacy Prices or Patient Assistance Programs. Suitable for insured, underinsured or uninsured individuals.

  6. 13 de ago. de 2022 · Linzess (linaclotide) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat the following conditions in adults: chronic idiopathic constipation (CIC)

  7. USES. LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown.